Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1928 1
1948 1
1963 1
1967 5
1968 2
1969 4
1970 5
1971 2
1972 4
1973 3
1975 2
1976 2
1977 5
1978 7
1979 6
1980 6
1981 4
1982 5
1983 7
1984 5
1985 6
1986 3
1987 1
1988 1
1989 2
1991 1
1992 1
1995 1
1997 1
1998 1
2000 4
2001 1
2002 4
2003 2
2004 1
2005 1
2006 6
2007 1
2008 2
2009 4
2010 8
2011 4
2012 6
2013 9
2014 3
2015 10
2016 8
2017 5
2018 13
2019 8
2020 20
2021 14
2022 10
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Results by year

Filters applied: . Clear all
Page 1
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial.
Bebin EM, Peters JM, Porter BE, McPherson TO, O'Kelley S, Sahin M, Taub KS, Rajaraman R, Randle SC, McClintock WM, Koenig MK, Frost MD, Northrup HA, Werner K, Nolan DA, Wong M, Krefting JL, Biasini F, Peri K, Cutter G, Krueger DA; PREVeNT Study Group. Bebin EM, et al. Among authors: mcpherson to. Ann Neurol. 2023 Aug 28:10.1002/ana.26778. doi: 10.1002/ana.26778. Online ahead of print. Ann Neurol. 2023. PMID: 37638552
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial.
Flohr C, Rosala-Hallas A, Jones AP, Beattie P, Baron S, Browne F, Brown SJ, Gach JE, Greenblatt D, Hearn R, Hilger E, Esdaile B, Cork MJ, Howard E, Lovgren ML, August S, Ashoor F, Williamson PR, McPherson T, O'Kane D, Ravenscroft J, Shaw L, Sinha MD, Spowart C, Taams LS, Thomas BR, Wan M, Sach TH, Irvine AD; TREAT Trial Investigators. Flohr C, et al. Among authors: mcpherson t. Br J Dermatol. 2023 Nov 16;189(6):674-684. doi: 10.1093/bjd/ljad281. Br J Dermatol. 2023. PMID: 37722926 Free article. Clinical Trial.
Natalizumab-induced acquired perforating dermatosis.
Fisher RM, Hadley G, Ieremia E, Moswela O, Zaki F, DeLuca GC, McPherson T. Fisher RM, et al. Among authors: mcpherson t. Clin Exp Dermatol. 2021 Oct;46(7):1373-1375. doi: 10.1111/ced.14699. Epub 2021 Jun 4. Clin Exp Dermatol. 2021. PMID: 34086353 No abstract available.
Stability of Olmesartan Medoxomil Extemporaneous Suspensions.
Bhattarai P, McPherson T, Nieto M, Kolling WM. Bhattarai P, et al. Among authors: mcpherson t. J Pharm Technol. 2022 Feb;38(1):3-9. doi: 10.1177/87551225211051756. Epub 2021 Oct 27. J Pharm Technol. 2022. PMID: 35141721 Free PMC article.
Breaking out of the shy silo.
McPherson T. McPherson T. Can Vet J. 2018 Jul;59(7):695-697. Can Vet J. 2018. PMID: 30026616 Free PMC article. No abstract available.
Vulval lichen sclerosus and lichen planus.
McPherson T, Cooper S. McPherson T, et al. Dermatol Ther. 2010 Sep-Oct;23(5):523-32. doi: 10.1111/j.1529-8019.2010.01355.x. Dermatol Ther. 2010. PMID: 20868406 Review.
Stability and compatibility study guidelines for AJHP.
McPherson T, Kolling WM. McPherson T, et al. Am J Health Syst Pharm. 2023 Sep 7;80(18):1271-1274. doi: 10.1093/ajhp/zxad132. Am J Health Syst Pharm. 2023. PMID: 37280164 No abstract available.
244 results